Top Health Care companies in Australia by EBT Margin

This ranking features the top 33 Health Care companies in Australia ranked by EBT Margin, averaging a EBT Margin of -10,436.46%, for January 15, 2025.

Australia

Health Care

#	Name	EBT Margin	Reported Date	Stock Price	Change	Country
1	Pro Medicus Limited 1 PME.AX	72.13%	June 30, 2024	USD 157.25	0.24%	Australia
2	Clinuvel Pharmaceuticals Limited 2 CUV.AX	57.47%	June 30, 2024	USD 7.32	6.16%	Australia
3	CSL Limited 3 CSL.AX	22.97%	June 30, 2024	USD 173.13	0.11%	Australia
4	SDI Limited 4 SDI.AX	13.70%	June 30, 2024	USD 0.71	1.12%	Australia
5	Medibank Private Limited 5 MPL.AX	8.87%	June 30, 2024	USD 2.35	0.77%	Australia
6	Sonic Healthcare Limited 6 SHL.AX	8.18%	June 30, 2024	USD 17.28	1.26%	Australia
7	Nanosonics Limited 7 NAN.AX	7.57%	June 30, 2024	USD 2.01	-0.68%	Australia
8	Ansell Limited 8 ANN.AX	6.71%	June 30, 2024	USD 21.11	1.40%	Australia
9	Pacific Smiles Group Limited 9 PSQ.AX	6.03%	June 30, 2024	USD 1.21	0.76%	Australia
10	Australian Clinical Labs Limited 10 ACL.AX	5.27%	June 30, 2024	USD 2.14	0.82%	Australia
11	Viva Leisure Limited 11 VVA.AX	2.96%	June 30, 2024	USD 0.84	-1.22%	Australia
12	EBOS Group Limited 12 EBO.AX	2.90%	June 30, 2024	USD 20.43	1.47%	Australia
13	Ramsay Health Care Limited 13 RHC.AX	2.31%	June 30, 2024	USD 21.27	2.57%	Australia
14	PolyNovo Limited 14 PNV.AX	1.66%	June 30, 2024	USD 1.33	6.17%	Australia
15	Telix Pharmaceuticals Limited 15 TLX.AX	0.62%	Dec. 31, 2023	USD 15.47	4.25%	Australia
16	Sigma Healthcare Limited 16 SIG.AX	0.26%	Jan. 31, 2024	USD 1.81	-0.44%	Australia
17	Regis Healthcare Limited 17 REG.AX	-2.77%	June 30, 2024	USD 3.89	3.70%	Australia
18	Monash IVF Group Limited 18 MVF.AX	-4.18%	June 30, 2024	USD 0.76	1.07%	Australia
19	Integral Diagnostics Limited 19 IDX.AX	-12.15%	June 30, 2024	USD 1.81	-0.10%	Australia
20	Cyclopharm Limited 20 CYC.AX	-15.44%	Dec. 31, 2023	USD 1.27	-1.68%	Australia
21	Trajan Group Holdings Limited 21 TRJ.AX	-20.07%	June 30, 2024	USD 0.62	-2.68%	Australia
22	Healius Limited 22 HLS.AX	-37.23%	June 30, 2024	USD 0.87	0.96%	Australia
23	Mayne Pharma Group Limited 23 MYX.AX	-48.97%	June 30, 2024	USD 2.80	2.04%	Australia
24	Immuron Limited 24 IMRN	-141.49%	June 30, 2024	USD 2.00	1.52%	Australia
25	PYC Therapeutics Limited 25 PYC.AX	-252.36%	June 30, 2024	USD 0.74	-1.40%	Australia
26	Clarity Pharmaceuticals Ltd 26 CU6.AX	-365.26%	June 30, 2024	USD 2.37	1.84%	Australia
27	Alterity Therapeutics Limited 27 ATHE	-474.65%	June 30, 2024	USD 3.31	-4.06%	Australia
28	Immutep Limited 28 IMMP	-1,111.87%	June 30, 2024	USD 1.93	-0.52%	Australia
29	Kazia Therapeutics Limited 29 KZIA	-1,171.97%	June 30, 2024	USD 1.53	1.32%	Australia
30	Mesoblast Limited 30 MSB.AX	-1,493.51%	June 30, 2024	USD 1.58	-2.06%	Australia
31	Anteris Technologies Ltd 31 AVR.AX	-1,680.35%	Dec. 31, 2023	USD 5.88	0.14%	Australia
32	Incannex Healthcare Limited 32 IXHL	-153,575.00%	June 30, 2024	USD 1.77	-1.67%	Australia
33	Opthea Limited 33 OPT	-184,215.67%	June 30, 2024	USD 3.82	6.70%	Australia

Frequently Asked Questions

Which Health Care company in Australia has the highest EBT Margin ?

The Health Care company in Australia with the highest EBT Margin is Pro Medicus Limited (ASX: PME.AX) at 72.13%.
Which Health Care company in Australia has the lowest EBT Margin ?

The Health Care company in Australia with the lowest EBT Margin is Opthea Limited (NasdaqGS: OPT) at -184,215.67%.

What are the top 10 Health Care companies in Australia by EBT Margin ?

The top 10 Health Care companies in Australia by EBT Margin are Pro Medicus Limited, Clinuvel Pharmaceuticals Limited, CSL Limited, SDI Limited, Medibank Private Limited, Sonic Healthcare Limited, Nanosonics Limited, Ansell Limited, Pacific Smiles Group Limited and Australian Clinical Labs Limited.
What are the bottom 10 Health Care companies in Australia by EBT Margin ?

The bottom 10 Health Care companies in Australia by EBT Margin are Opthea Limited, Incannex Healthcare Limited, Anteris Technologies Ltd, Mesoblast Limited, Kazia Therapeutics Limited, Immutep Limited, Alterity Therapeutics Limited, Clarity Pharmaceuticals Ltd, PYC Therapeutics Limited and Immuron Limited.